"Optum is a leading information and technology-enabled health services business dedicated to helping make the health system work better for everyone. With more than 180,000 people worldwide, Optum delivers intelligent, integrated solutions that help to modernize the health system and improve overall population health. Optum is part of UnitedHealth Group (NYSE:UNH)."

During the past decade, Colorado Springs Health Partners conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Colorado Springs Health Partners" #1 sponsor was "ByHeart" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Cogentus Pharmaceuticals" with 1 trials sponsored, "Elcelyx Therapeutics, Inc." with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Colorado Springs Health Partners" #1 collaborator was "Paidion Research, Inc." with 2 trials as a collaborator and "CoLucid Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Colorado Springs Health Partners" are "Cardiovascular Disease" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Colorado Springs Health Partners" in a lesser frequency.

Most popular intervention types in "Colorado Springs Health Partners" are "Drug" (9 trials), "Other" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Comparator Formula (CF)" (2 trials), "Study Formula (SF)" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Colorado Springs Health Partners" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Colorado Springs Health Partners". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Colorado Springs Health Partners, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Colorado Springs Health Partners, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".